B4GALNT3 can act both as tumor suppressor in neuroblastoma [11] and as oncogene in the colon, increasing the malignant phenotype of colon cancer cells through enhanced integrin and MAPK signaling [12]. This evidence concerns the gene B4GALNT3 and colonic neoplasm.